Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Shortage reports
Actual shortage:
214 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
2706 (92%)
2930
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
298 (99%)
Reversed:
0 (0%)
300
363 (11%)
99 (46%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-TADALAFIL | 10MG | TABLET | Resolved | 2021-06-03 | 2021-06-10 | 140378 |
| TEVA-TADALAFIL | 20MG | TABLET | Resolved | 2023-12-07 | 2024-04-18 | 212725 |
| TEVA-TADALAFIL | 5MG | TABLET | Resolved | 2024-03-28 | 2024-04-25 | 223859 |
| TEVA-TADALAFIL | 2.5MG | TABLET | Resolved | 2024-04-25 | 2024-09-19 | 226177 |
| TEVA-TADALAFIL | 20MG | TABLET | Resolved | 2020-10-01 | 2020-10-08 | 125479 |
| TEVA-TADALAFIL | 5MG | TABLET | Resolved | 2019-08-22 | 2019-09-26 | 92160 |
| TEVA-TAMOXIFEN | 20MG | TABLET | Resolved | 2018-03-16 | 2018-05-30 | 43171 |
| TEVA-TAMOXIFEN | 20MG | TABLET | Resolved | 2018-03-16 | 2018-05-30 | 43174 |
| TEVA-TAMOXIFEN | 20MG | TABLET | Resolved | 2018-10-11 | 2019-04-27 | 63757 |
| TEVA-TAMOXIFEN | 10MG | TABLET | Resolved | 2019-08-22 | 2020-02-21 | 92183 |
| TEVA-TAMOXIFEN | 20MG | TABLET | Resolved | 2019-08-22 | 2020-05-14 | 92186 |
| TEVA-TAMOXIFEN | 10MG | TABLET | Resolved | 2019-08-22 | 2020-02-21 | 92189 |
| TEVA-TAMOXIFEN | 10MG | TABLET | Resolved | 2022-03-24 | 2022-12-02 | 157256 |
| TEVA-TAMOXIFEN | 10MG | TABLET | Resolved | 2022-06-09 | 2022-11-12 | 162306 |
| TEVA-TAMOXIFEN | 20MG | TABLET | Resolved | 2019-09-19 | 2020-05-14 | 94381 |
| TEVA-TAMOXIFEN | 20MG | TABLET | Actual shortage | 2024-02-09 | 2024-05-23 | 219038 |
| TEVA-TAMOXIFEN | 10MG | TABLET | Actual shortage | 2024-04-05 | 2024-04-05 | 224454 |
| TEVA-TAMOXIFEN | 20MG | TABLET | Resolved | 2017-04-03 | 2017-05-10 | 5226 |
| TEVA-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-05-12 | 2022-12-15 | 160454 |
| TEVA-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-02-18 | 2021-05-13 | 134343 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
| ACT ETIDROCAL | 400MG 500MG | TABLET | Discontinued | 2019-02-21 | 2019-03-01 | 76486 |
| ACT LEVETIRACETAM | 500MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104304 |
| ACT NABILONE | 0.5MG | CAPSULE | Discontinued | 2021-09-23 | 2021-09-23 | 146066 |
| ACT NABILONE | 1MG | CAPSULE | Discontinued | 2019-10-31 | 2019-11-01 | 97581 |
| ACT NABILONE | 0.5MG | CAPSULE | Discontinued | 2020-10-15 | 2020-10-15 | 126452 |
| ACT OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2019-10-25 | 2019-10-26 | 97256 |
| ACT OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-01-24 | 2020-01-24 | 104277 |
| ACT OLMESARTAN | 20MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117497 |
| ACT OLMESARTAN | 40MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117500 |
| ACT OLMESARTAN HCT | 40MG 12.5MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117516 |
| ACT OLMESARTAN HCT | 20MG 12.5MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117513 |
| ACT OLMESARTAN HCT | 40MG 25MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117519 |
| ACT OXYCODONE CR | 20MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63986 |
| ACT OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63989 |
| ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
| ACT OXYCODONE CR | 10MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63983 |
| ACT OXYCODONE CR | 5MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65328 |
| ACT PROGESTERONE INJECTION | 50MG | SOLUTION | Discontinued | 2025-04-29 | 2025-04-29 | 256082 |